These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9683826

  • 21. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
    Strum SB, McDermed JE, Liponi DF.
    J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G, Krzakowski M, Pawinski A, Lasota W, Rogowski W, Skoneczna I.
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [Abstract] [Full Text] [Related]

  • 24. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U, Drechsler S, Eggert J, Gosse H, Ukena D, Imhoff W, Faerber L.
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [Abstract] [Full Text] [Related]

  • 25. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
    Bhatia A, Tripathi KD, Sharma M.
    Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S, Chareoniam V, Isariyodom P, Sungsab D.
    J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
    [Abstract] [Full Text] [Related]

  • 30. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG, Gralla RJ, Tyson LB, Clark RA, Cirrincione C, Groshen S.
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [Abstract] [Full Text] [Related]

  • 31. Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.
    Grunberg SM.
    Blood Rev; 1989 Dec; 3(4):216-21. PubMed ID: 2692744
    [Abstract] [Full Text] [Related]

  • 32. High-dose dexamethasone and high-dose metoclopramide versus high-dose dexamethasone and sulpiride in the management of cisplatin-induced emesis.
    Rosenblatt E, Lev LM, Robinson E.
    Oncology; 1988 Dec; 45(4):297-9. PubMed ID: 3387033
    [Abstract] [Full Text] [Related]

  • 33. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [Abstract] [Full Text] [Related]

  • 34. Managing chemotherapy-induced nausea and vomiting in head and neck cancer patients receiving cisplatin chemotherapy with concurrent radiation.
    Stinson J, Chan K, Lee J, Chow R, Cheon P, Giotis A, Pasetka M, Wan BA, Chow E, DeAngelis C.
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S13-S20. PubMed ID: 28595433
    [Abstract] [Full Text] [Related]

  • 35. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul 11; 340(8811):96-9. PubMed ID: 1352024
    [Abstract] [Full Text] [Related]

  • 36. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
    Senn HJ, Köhler M, Glaus A, Bachmann-Mettler I, Weigand W.
    Dtsch Med Wochenschr; 1986 Jan 24; 111(4):129-35. PubMed ID: 3510848
    [Abstract] [Full Text] [Related]

  • 37. Lack of antiemetic effect of high-dose metoclopramide.
    Roemeling RV, Christiansen NP, Hrushesky WJ.
    J Clin Oncol; 1985 Sep 24; 3(9):1273-6. PubMed ID: 4040959
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.